ISPOR Bridging Health Care Research and Practice   eBulletin Index

  

August 2006

  

ISPOR e-BULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org. Please share these new ISPOR activities with your colleagues.

 

NEW THIS MONTH

 

**NEW** Value in Health Short Notes

**NEW** Value in Health Vol. 9 No.4 (July/August 2006)

**NEW** ISPOR 9th European Congress-UPDATES

**NEW** ISPOR Special Interest Group (SIG) UPDATES

**NEW** 38 New Positions at the ISPOR Website

 

IMPORTANT DATES TO REMEMBER

 

Ø       26 September 2006 - Early registration deadline ISPOR 9th Annual European Congress, 28-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark 

Ø       28-31 October 2006 -  ISPOR 9th Annual European Congress, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Asia Consortium and Local Chapter News

8.       Employment in Pharmacoeconomics and Outcomes Research

9.       Membership

 


 

1.      PUBLICATIONS

Top

 

VALUE IN HEALTH

 

**NEW**

Value in Health Volume 9, Issue 4, July/August 2006

TABLE OF CONTENTS at: http://www.ispor.org/valueinhealth_index.asp

 

POLICY AND APPLICATION

Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999-2003

Michael J. Wonder, A. Munro Neville, Richard Parsons

           

            Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses

            Carmen A. Brauer, Allison B. Rosen, Dan Greenberg, Peter J. Neumann   

 

            EMPIRICAL

An Economic Evaluation of Two Ototopical Treatments for Acute Otitis Media in Tympanostomy Tube Patients

Peter S. Roland, Curtis R. Waycaster, G. Michael Wall, Jeffrey D. Glass

 

Estimating the Cost-Effectiveness of Fluticasone Propionate for Treating Chronic Obstructive Pulmonary Disease in the Presence of Missing Data

Andrew H. Briggs, Greta Lozano-Ortega, Sally Spencer, Geraldine Bale, Michael D. Spencer, P. Sherwood Burge

 

Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age

Judith A. O'Brien, J. Jaime Caro, Denis Getsios

 

METHODOLOGY

Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?

Susan Griffin, Karl Claxton, Neil Hawkins, Mark Sculpher

 

Indirect Costs and Cost-Effectiveness Analysis

Richard Ernst

 

Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population

Murtuza Bharmal, Joseph Thomas

 

SHORT NOTES

Fraction of Nursing Home Admissions Attributable to Urinary Incontinence

Alan Morrison, Richard Levy

 

CORRESPONDENCE

Applying the Grid Computation in Long-Term Retrospective Health Insurance Data Analysis

 

Is Rosuvastatin Really a More Efficient Therapeutic Option than Atorvastatin?

 

Formulary Decision-Making Should Rely on the Best Available Evidence

 

VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS

Manuscripts for Volume 9, Issue 5 are now posted. To view these "On-Line Early" manuscripts, simply go to http://www.ispor.org/valueinhealth_index.asp, log on using your membership information, and follow the link.

 

**NEW**

 VALUE IN HEALTH SHORT NOTES

Value in Health accepts short notes as well as full length research papers. A short note should include original results. Examples of short notes include papers estimating the cost of illness in a single country or site of care using standard methods; extensions of previously published studies that include new results, and reliability and validity studies for translations of patient reported outcome measures. For submission details, go to: http://www.ispor.org/publications/value/short_notes.asp

 


2.      ISPOR MEETINGS AND CONGRESSES

Top

 

ISPOR 9th ANNUAL EUROPEAN CONGRESS

Radisson SAS Falconer Hotel & Conference Center   

Copenhagen, Denmark 28-31 October 2006

  

**UPDATES**

 

FIRST PLENARY SESSION

Sunday, 29 October 2006, 13:30-15:00

HEALTH TECHNOLOGY ASSESSMENT (HTA) AS A BASIS FOR REIMBURSEMENT AND PRIORITIES IN HEALTH CARE

European and Industry Perspective Speaker: Richard Bergström MScPharm, Managing Director, Swedish Association of the Pharmaceutical Industry, Stockholm, Sweden

Government and Nordic Perspective Speaker: Audun Hagaa MSc, Deputy Director General, Ministry of Health, Oslo, Norway

For more information go to: http://www.ispor.org/congresses/denmark1006/102906.asp

 

SECOND PLENARY SESSION

Monday, 30 October 2006, 9:00-10:30

EVIDENCE BASED MEDICINE (EBM): TIME FOR ASKING CRITICAL QUESTIONS

EBM - Time for Asking Critical Questions?

Speaker: Ivar Sonbo Kristiansen MD, PhD, MPH, University of Oslo, Institute of Health Management and Health Economics, Oslo, Norway

EBM - Emerging Reality and Assorted Myths

Speaker: Paul Glasziou MD, Professor, Department of Primary Health Care Old Road Campus, University of Oxford, , Oxford, UK

For more information go to: http://www.ispor.org/congresses/denmark1006/103006.asp

 

THIRD PLENARY SESSION

Tuesday, 31 October 2006, 9:00-10:30

SOCIETAL VALUE OF A QALY

Looking for Willingness to Pay (WTP) Threshold for a QALY-- Does it make sense? -- A Critical View

Speaker: Dorte Gyrd-Hansen PhD, Professor, University of Southern Denmark, Institute of Public Health, Odense, Denmark

Looking for Willingness to Pay (WTP) Threshold for a QALY -- Does it make sense? -- A Practical View

Speaker: Martin Buxton BA Soc Sci, Professor, Brunel University Health Economics Research Group, Uxbridge, Middlesex, UK

For more information go to : http://www.ispor.org/congresses/denmark1006/103106.asp

 

EXHIBIT OPPORTUNITIES

Register now for Exhibit space:

 

SPONSORSHIP OPPORTUNITIES

Register for sponsorship promotional opportunities:

 

For more 9th Annual European Congress program info, go to:

http://www.ispor.org/congresses/denmark1006/index.asp

 


 

3.      EDUCATION ACTIVITIES

Top

           

ISPOR Short Courses Prior to the ISPOR 9TH Annual European Congress - October 2006

 

Sixteen short courses including 5 NEW courses will be given this year, with 9 courses on Saturday, 28 October, 2006, and 7 courses on Sunday, 29 October, 2006.

 

SATURDAY, 28 OCTOBER, 2006

 

**NEW**

Application of Item Response Theory in Patient Outcomes Measurement

 

**NEW**

Case Studies in Pharmaceutical/Biotech Pricing II - Advanced

 

**NEW**

Instrument Development and Evaluation for Patient-Reported Outcomes Assessment

 

For full descriptions of ALL Saturday short courses, please visit: http://www.ispor.org/congresses/denmark1006/sc102806.asp

 

SUNDAY, 29 OCTOBER, 2006

 

**NEW**

            Cost-Effectiveness Analysis alongside Clinical Trials

**NEW**

Pharmacoeconomic Modeling - Advanced


            For full descriptions of ALL Sunday short courses, please visit: http://www.ispor.org/congresses/denmark1006/sc102906.asp


 

4.      STUDENT NEWS

Top

 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp        


  

5.       ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

SPECIAL INTEREST GROUPS are very important to ISPOR to achieve its mission. Their goals are to: develop consensus; stimulate debate; advance knowledge/understanding; publish good research practices; develop indices & tools for researchers and decision-makers; compile health care information for public; respond to health care public policy.

 

HEALTH TECHNOLOGY ASSESSMENT IN EVIDENCE-BASED REIMBURSEMENT SIG

TRANSLATING RESEARCH TO PRACTICE SIG

PATIENT REGISTRY SIG

MEDICATION COMPLIANCE & PERSISTENCE SIG

 

RETROSPECTIVE DATABASE SIG

CO-CHAIRS:

Michael Johnson PhD, Associate Professor, University of Houston, College of Pharmacy; Michael E. DeBakey VA Medical Center, & Assistant Professor of Medicine, Baylor College of Medicine Houston, TX, USA

William D. Marder PhD, Senior Vice President & General Manager, Medstat, Cambridge, MA, USA

 

Mission:

To provide an international forum for ISPOR membership to identify and address comprehensive issues in the development and use of retrospective clinical, survey and administrative databases for pharmacoeconomic outcomes research.

 

Future Plans for Retrospective Database SIG:

A regrouping of this SIG group is now taking place.  Members of the Retrospective Database SIG group will be receiving an email with specific information on each group.  All members will be asked to respond indicating if they are interested in being an active member of the SIG and which working group they are interested in and the level – leadership or review group.

 

We would like to encourage any ISPOR member that is not a part of this SIG group, but would like to join, to please sign up at: http://www.ispor.org/sigs/sigsindex.asp

 

**NEW**

Patient-Reported Outcomes (PRO) SIG

ePRO Working Group (WG) Activated

 

The ISPOR PRO SIG ePRO WG is ready to start its activities. The goal of the ePRO WG is to identify relevant issues and develop ePRO good research practices.

 

If you are interested in participating on this Working Group, you can join either the Leadership Group (a small group of SIG members who develop the SIG initiatives and goals) Or Reviewer Group (larger group of SIG members who respond to / comment on 'work products' produced by the Leadership Working Group)

 

For information on the ePRO WG background, goals and tasks, visit http://www.ispor.org/sigs/PRO_e.asp 

 

RISK MANAGEMENT SIG

Following the ISPOR 11th Annual International Meeting, the Risk Management SIG put out a detailed plan of action for their activities for the upcoming year.  They will continue to focus on publishing their White Papers on Pharmaceutical Perspectives on Risk and plan to launch a nation-wide public survey on attitudes regarding risk.

 

For more information on the Risk Management SIG, visit http://www.ispor.org/sigs/rm.asp.

 


 

6.      ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

 

TASK FORCE ACTIVITIES

 

BUDGET IMPACT ANALYSIS TASK FORCE

 

For more on this Task Force, please visit http://www.ispor.org/workpaper/budget_impact.asp.


 

7.      LOCAL CHAPTER, ADVISORY COUNCIL, AND ASIA CONSORTIUM NEWS

Top

 

LOCAL CHAPTER

ISPOR India Chapter was formed in May 2006.

For more details on ISPOR Local Chapters, go to: Regional Chapters

 

ADVISORY COUNCIL

ISPOR Asia-Pacific Medical Device & Diagnostics Council was formed in March 2006.

For more details on ISPOR Advisory Councils, please visit: www.ispor.org

 

ASIA CONSORTIUM 

For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp

 


8.  EMPLOYMENT

Top

38 POSITIONS LISTED AT THE ISPOR WEBSITE: /Careers

 

Advertise your positions on ISPOR Website (~1 million hits per month)

 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at  STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available.  Nine student resumes posted!  EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students. If you have any questions, please contact: iprap@ispor.org. For more information, visit our website at:


 

9.  ISPOR MEMBERSHIP

Top

 

Update your contact information and email address at: https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log-in information in the members only section of the ISPOR website. 

 

 

 

 


eBulletin Index